Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

New gamma-secretase modulator shows promise in Alzheimer's disease models

Sep. 1, 2011

GABA-AT inhibitor shows promise to treat epilepsy and drug addiction

Sep. 1, 2011

Clinical data presented on doxazosin/dutasteride in men with benign prostatic hyperplasia

Aug. 31, 2011

Gilead discloses data on HCV NS3 inhibitor

Aug. 31, 2011

Novel inhibitors of chemokine CCR2/CCR5 receptors described

Aug. 31, 2011

First-in-class agent lowers blood pressure in patients with heart failure

Aug. 31, 2011

Brain-penetrant inhibitor of kynurenine aminotransferase II described by Pfizer

Aug. 30, 2011

Additional analyses of AVERROES study presented

Aug. 30, 2011

Pfizer describes discovery and investigation of AMPA receptor modulator now in phase I

Aug. 30, 2011

Bristol-Myers Squibb small-molecule MAP kinase p38 alpha inhibitor shows promise to treat arthritis

Aug. 30, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...